Algernon Pharmaceuticals Inc. reported earnings results for the first quarter ended November 30, 2023. For the first quarter, the company reported net loss was CAD 0.521554 million compared to CAD 1.88 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.2 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 CAD | -19.23% | +5.00% | +61.54% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+61.54% | 1.65M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.28% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- AGN Stock
- News Algernon Pharmaceuticals Inc.
- Algernon Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023